S.T. Stent
About S.T. Stent
S.T.Stent develops a composite removable sinus stent. The stent is designed to be placed into ethmoid sinus following functional endoscopic sinus surgery (FESS) to maintain the cavity open. FESS procedure is used to treat chronic sinusitis, which is one of the most common health problems in the modern world. However a single surgery often is not enough to cure the patient, due to post surgery scarring, stenosis and middle turbinate lateralization. Their devise is designed to keep the cavity open long enough for the healing process to complete itself. Their main innovation is based on the fact that the stent can be removed at any time, based on patient decision or physician consult. Stent removal is an in-office procedure, done without anesthesia, and is minimally invasive for the patient.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 533304 USD
- Last Funding: 71429 EUR (Grant)
- Funding Status: Seed
Technology Stack
S.T. Stent actively uses None products in their tech stack.
Market Presence
Industries: Health Care, Hospital, Medical
Headquarters: Misgav Dov, HaMerkaz, Israel